RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,042
MEDI-app based feedback algorithm. The app based feedback algorithm will check and remind the patients of taking medication.
Seoul National University Bundang Hospital
Seongnam, South Korea
RECRUITINGDrug adherence
Drug adherence by pill count
Time frame: 24 week
Proportion of adequate medication adherence at 24 weeks
proportion of patients with ≥95% of continuous medication adherence
Time frame: 24 weeks
The occurrence of clinical composite end point
composites of stroke, systemic embolic event, major bleeding requiring hospitalization or transfusion, or death.)
Time frame: 24 week
The occurrence of MACCE and hospitalization
MACCE plus hospitalization
Time frame: 24 week
The occurrence of Thromboembolism (Stroke, TIA, Pulmonary embolism)
Stroke, TIA, Pulmonary embolism)
Time frame: 24 week
The occurrence of bleeding
bleeding event
Time frame: 24 week
Drug adherence
Drug adherence by pill count
Time frame: 12 week
Proportion of adequate medication adherence at 12 weeks
proportion of patients with ≥95% of continuous medication adherence
Time frame: 12 week
medication adherence by zero-inflated model
medication adherence by zero-inflated model
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 week and 24 weeks